| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1016/j.jsgi.2006.05.004 Progestagenic Effects of Tibolone are Target GeneSpecific In Human Endometrial Cells
Department of Obstetrics/Gynecology and Reproductive Medicine, SUNY-Stony Brook, Stony Brook, New York; and N.V. Organon, Oss, the Netherlands. Supported by grants NIH HD 19247-16 and Organon 31480
Department of Obstetrics/Gynecology and Reproductive Medicine, SUNY-Stony Brook, Stony Brook, New York; and N.V. Organon, Oss, the Netherlands. Supported by grants NIH HD 19247-16 and Organon 31480; litseng{at}notes.cc.sunysb.edu Objectives: Tibolone (Tib) exhibits progestagenic activities in addition to its tissue-specific estrogenic activities. The purpose of the current study was to determine the progestagenic actions of Tib and its metabolites using target genes known to be regulated by progestins in human endometrial glandular and stromal cells. Methods: Human endometrial glandular and stromal cells were isolated from endometrial tissue fragments and separately incubated with Tib and its metabolites. Real-time polymerase chain reaction (PCR) was used to determine the mRNA content of 17ßhydroxy steroid dehydrogenase (17ßHSD, type 2) and sulfotransferase (SULT1E1) in endometrial glandular cells, and prolactin (PRL) and insulin-like growth factor binding protein-1 (IGFBP1) in endometrial stromal cells.
Results: In glandular cells, Tib and
Conclusions: The data showed that Tib and
Key Words: Tibolone progesterone 17ßHSD SULT1E1 PRL endometrium
|
4-tibolone (
30% of the capacity compared to progesterone) and had little effect on IGFBP1 mRNA. Anti-progestin, RU486, reversed the induction of SULT1E1 and PRL by progesterone or Tib. Also, the two 3 hydroxyl tobolone metabolites, especially 3ßOHTib, showed some progestagenic effects.